184 related articles for article (PubMed ID: 22997913)
21. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
Smilde TD; Asselbergs FW; Hillege HL; Voors AA; Kors JA; Gansevoort RT; van Gilst WH; de Jong PE; Van Veldhuisen DJ
Am J Hypertens; 2005 Mar; 18(3):342-7. PubMed ID: 15797651
[TBL] [Abstract][Full Text] [Related]
22. Gender-specific association of decreased estimated glomerular filtration rate and left vertical geometry in the general population from rural Northeast China.
Dai D; Chang Y; Chen Y; Yu S; Guo X; Sun Y
BMC Cardiovasc Disord; 2017 Jan; 17(1):24. PubMed ID: 28086799
[TBL] [Abstract][Full Text] [Related]
23. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
Kimura T; Iio K; Obi Y; Hayashi T
Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
[TBL] [Abstract][Full Text] [Related]
24. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
Chang JM; Chen SC; Huang JC; Su HM; Chen HC
Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
[TBL] [Abstract][Full Text] [Related]
25. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular hypertrophy in patients with chronic kidney disease under conservative treatment.
Bregman R; Lemos C; Pecoits Filho R; Abensur H; Draibe S; Bastos MG; Canziani ME
J Bras Nefrol; 2010 Mar; 32(1):83-8. PubMed ID: 21448524
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors of myocardial remodeling in hemodialysis patients.
Dimitrijevic Z; Cvetkovic T; Stojanovic M; Paunovic K; Djordjevic V
Ren Fail; 2009; 31(8):662-7. PubMed ID: 19817519
[TBL] [Abstract][Full Text] [Related]
28. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
[TBL] [Abstract][Full Text] [Related]
29. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
[TBL] [Abstract][Full Text] [Related]
30. Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease.
Zou J; Yu Y; Wu P; Lin FJ; Yao Y; Xie Y; Jiang GR
Int J Cardiol; 2016 Oct; 221():134-40. PubMed ID: 27400310
[TBL] [Abstract][Full Text] [Related]
31. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular hypertrophy among predialysis chronic kidney disease patients: Sindh institute of urology and transplantation experience.
Ali T; Idrees MK; ; Akhtar SF
Saudi J Kidney Dis Transpl; 2017; 28(6):1375-1380. PubMed ID: 29265050
[TBL] [Abstract][Full Text] [Related]
34. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
Leonardis D; Basta G; Mallamaci F; Cutrupi S; Pizzini P; Tripepi R; Tripepi G; De Caterina R; Zoccali C
Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
[TBL] [Abstract][Full Text] [Related]
35. [Left ventricular hypertrophy in chronic kidney disease].
Paoletti E; Cannella G
G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
Ulasi II; Arodiwe EB; Ijoma CK
Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
[TBL] [Abstract][Full Text] [Related]
37. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
[TBL] [Abstract][Full Text] [Related]
38. [Impact of day-to-day arterial pressure variability on the left ventricle geometry in patients with predialysis chronic kidney insufficiency].
Shutov AM; Kondrat'eva NI; Kulikova ES; Ivashkina TN
Ter Arkh; 2002; 74(6):42-5. PubMed ID: 12136482
[TBL] [Abstract][Full Text] [Related]
39. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients.
Okumura K; Io H; Matsumoto M; Seto T; Takagi M; Masuda A; Furukawa M; Nagahama L; Omote K; Hisada A; Hamada C; Horikoshi S; Tomino Y
Clin Nephrol; 2013 Jan; 79(1):7-14. PubMed ID: 23036229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]